Harbor Capital Advisors’s Health Catalyst HCAT Stock Holding History

Harbor Capital Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20K	Buy	+15,617	New	+$29.4K	﹤0.01%	834
2025 Q1	–	Sell	-10,886	Closed	-$77K	–	1465
2024 Q4	$77K	Sell	10,886 -878	-7%	-$6.99K	﹤0.01%	712
2024 Q3	$96K	Buy	11,764 +2,064	+21%	+$14.9K	﹤0.01%	721
2024 Q2	$62K	Sell	9,700 -14,250	-59%	-$91.5K	﹤0.01%	713
2024 Q1	$180K	Buy	23,950 +13,005	+119%	+$119K	0.02%	625
2023 Q4	$101K	Buy	10,945 +218	+2%	+$1.78K	0.02%	417
2023 Q3	$109K	Sell	10,727 -1,257	-10%	-$15K	0.02%	410
2023 Q2	$150K	Buy	+11,984	New	+$143K	0.03%	394

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

CDC Financial Chicago, Illinois $157M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

PVM

Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbor Capital Advisors's HCAT Position: Q1 2026 in Review

Harbor Capital Advisors opened a new position in Health Catalyst (HCAT) in Q1 2026: 15,617 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #834 among its holdings. This is a return to the name: Harbor Capital Advisors previously reported a position in HCAT as recently as Q4 2024.

Harbor Capital Advisors first reported a position in HCAT in Q2 2023 and has held it in 8 quarters since. The position peaked at $180K in Q1 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

Harbor Capital Advisors held 15,617 shares of Health Catalyst worth $20K as of Q1 2026.
Health Catalyst was a new Harbor Capital Advisors position in Q1 2026.
Health Catalyst made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #834 holding.
Harbor Capital Advisors first reported a position in Health Catalyst in Q2 2023 and has held it in 8 quarters since.
Harbor Capital Advisors's Health Catalyst position peaked at $180K in Q1 2024.
130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.